Sign in

CIK 0001082554 · Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
521984749
Phone
3016089292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$342,898,837
in 74 filings, $342.1M under 10b5-1 plans

Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-17 ROTHBLATT MARTINE A Chairperson & CEO Option exercise · Stock Option 10b5-1 −9,500 17,000
2026-04-17 PATUSKY CHRISTOPHER Director Option exercise 10b5-1 +1,000 $101.80 $102K 2,490
2026-04-17 PATUSKY CHRISTOPHER Director Sale 10b5-1 −1,000 $578.88 $579K 1,490
2026-04-17 PATUSKY CHRISTOPHER Director Option exercise · Stock Option 10b5-1 −1,000 2,910
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Option exercise 10b5-1 +10,000 $135.42 $1.4M 28,876
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −520 $573.91 $298K 28,356
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,680 $574.73 $966K 26,676
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −789 $575.64 $454K 25,887
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −2,206 $576.91 $1.3M 23,681
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −2,085 $577.87 $1.2M 21,596
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,066 $578.83 $617K 20,530
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,454 $579.64 $843K 19,076
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −160 $581.08 $93K 18,916
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −40 $581.64 $23K 18,876
2026-04-16 EDGEMOND JAMES CFO AND TREASURER Option exercise · Stock Option 10b5-1 −10,000 82,500
2026-04-16 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 10b5-1 +9,500 $146.03 $1.4M 50,013
2026-04-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −400 $573.96 $230K 49,613
2026-04-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −1,800 $574.79 $1.0M 47,813
2026-04-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −930 $575.99 $536K 46,883
2026-04-16 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −2,048 $577.03 $1.2M 44,835

Page 122 of 171 · 3,408 trades